ATE332376T1 - Bakterielle ausscheidungsproteine und darauf beruhende azelluläre impfstoffe - Google Patents

Bakterielle ausscheidungsproteine und darauf beruhende azelluläre impfstoffe

Info

Publication number
ATE332376T1
ATE332376T1 AT94927328T AT94927328T ATE332376T1 AT E332376 T1 ATE332376 T1 AT E332376T1 AT 94927328 T AT94927328 T AT 94927328T AT 94927328 T AT94927328 T AT 94927328T AT E332376 T1 ATE332376 T1 AT E332376T1
Authority
AT
Austria
Prior art keywords
bacterial
proteins
pct
nucleic acids
vaccines
Prior art date
Application number
AT94927328T
Other languages
English (en)
Inventor
H Robert Masure
Barbara J Pearce
Elaine Tuomanen
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Application granted granted Critical
Publication of ATE332376T1 publication Critical patent/ATE332376T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/03—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with oxygen as acceptor (1.2.3)
    • C12Y102/03003—Pyruvate oxidase (1.2.3.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT94927328T 1993-09-01 1994-09-01 Bakterielle ausscheidungsproteine und darauf beruhende azelluläre impfstoffe ATE332376T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11654193A 1993-09-01 1993-09-01
US08/245,511 US5928900A (en) 1993-09-01 1994-05-18 Bacterial exported proteins and acellular vaccines based thereon

Publications (1)

Publication Number Publication Date
ATE332376T1 true ATE332376T1 (de) 2006-07-15

Family

ID=26814346

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94927328T ATE332376T1 (de) 1993-09-01 1994-09-01 Bakterielle ausscheidungsproteine und darauf beruhende azelluläre impfstoffe

Country Status (14)

Country Link
US (2) US5928900A (de)
EP (1) EP0721506B1 (de)
JP (1) JP3722834B2 (de)
AT (1) ATE332376T1 (de)
AU (1) AU709405B2 (de)
CA (1) CA2170726A1 (de)
DE (1) DE69434784T2 (de)
DK (1) DK0721506T3 (de)
ES (1) ES2267096T3 (de)
FI (1) FI960977L (de)
NO (1) NO321826B1 (de)
NZ (1) NZ273497A (de)
PT (1) PT721506E (de)
WO (1) WO1995006732A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031548A1 (en) * 1994-05-16 1995-11-23 The Uab Research Foundation Streptococcus pneumoniae capsular polysaccharide genes and flanking regions
US5834278A (en) * 1996-05-01 1998-11-10 The Rockefeller University Bacterial peptide methionine sulfoxide reductase an adhesion-associated protein, and antibiotic therapies based thereon
US6245335B1 (en) 1996-05-01 2001-06-12 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
US6165989A (en) * 1996-05-14 2000-12-26 Smithkline Beecham Corporation Era of Streptococcus pneumoniae
WO1998006734A1 (en) * 1996-08-16 1998-02-19 Smithkline Beecham Corporation Novel prokaryotic polynucleotides, polypeptides and their uses
US5928895A (en) * 1996-09-24 1999-07-27 Smithkline Beecham Corporation IgA Fc binding protein
US5882896A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation M protein
US5882871A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation Saliva binding protein
JP4469026B2 (ja) * 1996-10-31 2010-05-26 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｎｅｕｍｏｎｉａｅの抗原およびワクチン
JP2002503087A (ja) 1996-11-12 2002-01-29 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ ストレプトコッカス・ニューモニアのｃ３結合タンパク質
US20040242522A1 (en) * 1997-02-14 2004-12-02 Volkin David B. Polynucleotide vaccine formulations
US6676943B1 (en) 1997-04-24 2004-01-13 Regents Of The University Of Minnesota Human complement C3-degrading protein from Streptococcus pneumoniae
AU5070999A (en) * 1998-07-22 2000-02-14 Id-Lelystad (streptococcus suis) vaccines and diagnostic tests
ATE361365T1 (de) * 1998-07-27 2007-05-15 Sanofi Pasteur Ltd Streptococcus pneumoniae proteine und nukleinsäuren
WO2000006736A2 (en) * 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
EP1801218A3 (de) * 1998-07-27 2007-10-10 Sanofi Pasteur Limited Nukleinsäuren und Proteine aus Pneumokokken
CN1318103A (zh) * 1998-07-27 2001-10-17 微生物技术有限公司 肺炎链球菌的核酸和蛋白质
EP1785486A3 (de) * 1998-07-27 2007-08-08 Sanofi Pasteur Limited Pneumokokkenproteine und Nukleinsäuremoleküle
US20030134407A1 (en) 1998-07-27 2003-07-17 Le Page Richard William Falla Nucleic acids and proteins from Streptococcus pneumoniae
EP1624064A3 (de) * 1998-07-27 2006-05-10 Microbial Technics Limited Nukleinsäuren und entsprechende Proteine aus streptococcus pneumoniae
US6936252B2 (en) 1998-07-27 2005-08-30 Microbial Technics Limited Streptococcus pneumoniae proteins and nucleic acid molecules
US7098182B2 (en) 1998-07-27 2006-08-29 Microbial Technics Limited Nucleic acids and proteins from group B streptococcus
EP1140157B1 (de) 1998-12-21 2009-02-18 MedImmune, Inc. Streptococcus pneumoniae proteine und immunogene fragmente für impstoffe
GB9921125D0 (en) * 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
JP2003531149A (ja) 2000-04-13 2003-10-21 ザ・ロツクフエラー・ユニバーシテイ 抗体由来の免疫応答の増強
EP1205552A1 (de) * 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Streptokokkenvirulenz mit ORF aus Streptococcus suis
CA2436530C (en) 2001-02-02 2013-10-01 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Environmentally regulated genes of streptococcus suis
US20030082595A1 (en) * 2001-08-03 2003-05-01 Bo Jiang Nucleic acids of aspergillus fumigatus encoding industrial enzymes and methods of use
NO20026286D0 (no) * 2002-12-30 2002-12-30 Amersham Health As Nye peptider
RU2286576C2 (ru) * 2004-12-21 2006-10-27 Волгоградский научно-исследовательский противочумный институт Способ выявления перекрестнореагирующих антигенов возбудителей мелиоидоза, сапа, чумы, туляремии и туберкулеза
EP2023143A1 (de) * 2007-08-06 2009-02-11 Boehringer Ingelheim Vetmedica Gmbh Immunogene Streptokokkus-Proteine
EP2897638A1 (de) 2012-09-24 2015-07-29 Montana State University-Bozeman Rekombinanter lactococcus lactis zur expression des escherichia coli-kolonisationsfaktor-antigens i (cfa/i) fimbriae und verfahren zu deren verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3886225T2 (de) * 1987-01-06 1994-03-31 Asahi Chemical Ind Pyruvat-Oxidase, ihre Herstellung und Verwendung.
WO1990006951A1 (en) * 1988-12-16 1990-06-28 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Pneumolysin mutants and pneumococcal vaccines made therefrom
FI933580A7 (fi) * 1991-02-15 1993-10-13 Uab Research Foundation Pneumokokkiproteiinin rakennegeeni
WO1993010238A1 (en) * 1991-11-14 1993-05-27 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Pneumococcal fimbrial protein a vaccines
EP0672123A1 (de) * 1992-01-08 1995-09-20 The Rockefeller University Multifunktionale Oberflächeprotein von Streptokokken

Also Published As

Publication number Publication date
FI960977A7 (fi) 1996-04-30
JP3722834B2 (ja) 2005-11-30
NO960839D0 (no) 1996-02-29
DE69434784D1 (de) 2006-08-17
JPH09504686A (ja) 1997-05-13
NO960839L (no) 1996-04-19
CA2170726A1 (en) 1995-03-09
WO1995006732A2 (en) 1995-03-09
US5981229A (en) 1999-11-09
AU709405B2 (en) 1999-08-26
FI960977L (fi) 1996-04-30
US5928900A (en) 1999-07-27
WO1995006732A3 (en) 1995-06-01
AU7680994A (en) 1995-03-22
ES2267096T3 (es) 2007-03-01
EP0721506B1 (de) 2006-07-05
DE69434784T2 (de) 2007-06-14
NZ273497A (en) 1998-03-25
DK0721506T3 (da) 2006-10-30
NO321826B1 (no) 2006-07-10
PT721506E (pt) 2006-10-31
FI960977A0 (fi) 1996-03-01
EP0721506A1 (de) 1996-07-17

Similar Documents

Publication Publication Date Title
ATE332376T1 (de) Bakterielle ausscheidungsproteine und darauf beruhende azelluläre impfstoffe
EA200100565A1 (ru) Новые стрептококковые антигены
GEP20032977B (en) Proteinase K-Resistant Surface Protein of Neisseria Meningitidis
MXPA02001911A (es) Anticuerpos ctla-4 humanos y sus usos.
KR100202128B1 (en) Vaccine against lyme disease
ZA954641B (en) Polynucleotide vaccine for papilloma virus
NL300433I1 (en) Methods and compositions for the treatment of glomerulonephritis
BR9509099A (pt) Novas proteínas e cepas pesticidas
GR3003937T3 (de)
AU1915995A (en) Active immunization using a siderophore receptor protein
DK22389D0 (da) Fremgangsmaade og middel til beskyttelse mod sygdomme foraarsaget af mikroorganismer, navnlig mycoplasma
GR3031698T3 (en) Vaccine against Streptococcus suis infection.
DK0418945T3 (da) Forgreningsenzym og dets anvendelse
GB9526178D0 (en) Novel polynuceotides and polypeptides in pathogenic mycobacteria and their use as diagnostics,vaccines and targets for chemotherapy
DK0840792T3 (da) (S)-hydroxynitrillyase fra Hevea brasiliensis
DE69116803D1 (de) Peroxidase-Gen von mikrobischem Ursprung
PT648836E (pt) Transactivador do mhc de classe ii (ciita) e suas utilizacoes
GR880100247A (en) Bacillus thuringiensis p-2 toxin gene protein and related insecticide compositions
DE69330246D1 (de) Impfstoffe auf der basis von streptokinase
AU6108794A (en) Substituted heteroarylalkylthiopyridines for controlling helicobacter bacteria
WO1997014798A3 (de) Polynukleotide und die durch diese kodierrte proteine, geeignet zur bekämpfung von melolontha sp.käfern
WO1998014567A3 (en) Methods and compositions for inhibiting bacterial growth
BR8701162A (pt) Fragmento de adn,substancia proteinacea,proteina,vetor,microorganismo,sistema de bioencapsulacao,metodo para produzir um fragmento de adn,metodo para combater insetos,composicao inseticida,vetor hibrido,levedura e bacteria
DE60114876D1 (de) DEKONTAMINATION VON PRIONHALTIGEM (z.B. BSE-AGENS ENTHALTENDEM) TIERFUTTER
ATE77831T1 (de) Verfahren zur gewinnung von insektenpathogenen proteinen und mikroorganismen des typs bacillus thuringiensis.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0721506

Country of ref document: EP

REN Ceased due to non-payment of the annual fee